ChenH-Y, ChauhanSP. Hypertension among women of reproductive age: Impact of 2017 American College of Cardiology/American Heart Association high blood pressure guideline. Int J Cardiol Hypertens, 2019; 1:1–6.
2.
GuoN, RobakisT, MillierC, ButwickA. Prevalence of depression among women of reproductive age in the United States. Obstet Gynecol, 2018; 131:671–679.
3.
ACOG Practice Bulletin. Gestational hypertension and preeclampsia. American College of Obstetricians and Gynecologists. Obstet Gynecol, 2019; 133:e1–e25.
4.
ACOG Practice Bulletin. Chronic hypertension in pregnancy. American College of Obstetricians and Gynecologists. Obstet Gynecol, 2019; 133:e26–e50.
5.
CastroLC, HobelCJ. Hypertensive disorders of pregnancy. In: HackerN, GamboneJ, HobelC, eds. Essentials of obstetrics and gynecology, 6th ed. Philadelphia: Elsevier, 2016:183–193.
6.
SayL, ChouD, GemmillA. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health, 2014; 2:e323–e333.
7.
Screening for perinatal depression. ACOG Committee Opinion No. 757. American College of Obstetricians and Gynecologists. Obstet Gynecol, 2018; 132:e208–e212.
8.
LancasterCA, GoldKJ, FlynnHA, YooH, MarcusSM, DavisMM. Risk factors for depressive symptoms during pregnancy: A systematic review. Am J Obstet Gynecol, 2010; 1:5–14.
9.
AccorttEE, CheadleAC, SchetterCD. Prenatal depression and adverse birth outcomes: An updated systematic review. Maternal Child Health J, 2015; 19:1306–1337.
10.
GrigoriadisS, VonderPortenEH, MamisashviliL, et al.The impact of maternal depression on perinatal outcomes: A systematic review and meta-analysis. J Clin Psychiatry, 2013; 74:e321–e341.
11.
GroteNK, BridgeJA, GavinAR, MelvilleJL, IyengarS, KatonWJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry, 2010; 67:1012–1024.
12.
RäisänenS, LehtoSM, NielsenHS, et al.Risk factors for and perinatal outcomes of major depression during pregnancy: A population-based analysis during 2002–2010 in Finland. BMJ Open, 2014; 4:e004883.
13.
WatersCS, HayDF, SimmondsJR, van GoozenSHM. Antenatal depression and children's developmental outcomes: Potential mechanisms and treatment options. Eur Child Adolesc Psychiatry, 2014; 23:957–971.
14.
ElixhauserA, SteinerC, HarrisDR, CoffeyRM. Comorbidity measures for use with administrative data. Med Care, 1998; 36:8–27.
15.
BatemanBT, MhyreJM, Hernandez-DiazS, et al.Development of a comorbidity index for use in obstetric patients. Obstet Gynecol, 2013; 122:957–965.
16.
MogosMF, JonesLM, RobinsonNS, WhiteheadA, PiscottyR, GobaGK. Prevalence, correlates, and outcomes of co-occurring depression and hypertensive disorders of pregnancy. J Women's Health, 2019; 28:1460–1467.
17.
Screening for Depression: Recommendations from the U.S. Preventive Services Task Force. Ann Intern Med, 2002; 136:1–56.
18.
HaasDM, ImperialeTF, KirkpatrickPR, KleinRW, ZollingerTW, GolichowskiAM. Tocolytic therapy: A meta-analysis and decision analysis. Obstet Gynecol, 2009; 113:585–594.
19.
Fetal growth restriction. ACOG Practice Bulletin No. 204. American College of Obstetricians and Gynecologists. Obstet Gynecol, 2019; 133:e97–e109.
